Clover Health Investments, Corp. (CLOV) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to Clover Health's fourth quarter 2025 earnings call. We ask that you please hold all questions until the completion of the formal remarks, at which time you will be given instructions for the question and answer session. Also, as a reminder, this conference is being recorded today. If you have any objections, please disconnect at this time. Ryan, you may begin. good afternoon everyone joining me on our call today to discuss the company's fourth quarter and full year 2025 results are andrew toy cloverhealth's chief executive officer and peter kypers the company's chief financial officer you can find today's press release in the accompanying supplemental slides as well as the company's most recent investor deck in the investor events and presentation section of our website at investors.cloverhealth.com This webcast is being recorded and a replay will be available in the investor relations section of the Clover Health website. I'd also like to caution you that we may make forward-looking statements during today's call that are subject to risks and uncertainties, including expectations about future performance. Factors that may cause actual results to differ materially from expectations are detailed in our SEC filings, including in the risk factors section of our most recent annual report on Form 10-K and other SEC filings. Information about non-GAAP financial measures referenced, including a reconciliation of those measures to GAAP measures, can be found in the earnings materials available on our website. With that, I'll now turn the call over to Andrew. Thank you, Ryan, and welcome everyone to Clover's fourth quarter earnings call. The headline takeaway is this. In 2025, we achieved full-year adjusted EBITDA profitability, delivered a well-controlled...